2023 - Research.com Best Scientist Award
2023 - Research.com Medicine in France Leader Award
2022 - Research.com Best Scientist Award
2022 - Research.com Medicine in France Leader Award
His study deals with a combination of Internal medicine and Family medicine. Alternative medicine and Placebo are two areas of study in which Maxime Dougados engages in interdisciplinary work. He regularly ties together related areas like Randomized controlled trial in his Pathology studies. He integrates many fields, such as Randomized controlled trial and Alternative medicine, in his works. Maxime Dougados performs integrative Rheumatoid arthritis and Rheumatism research in his work. He integrates Rheumatism with Rheumatology in his study. Maxime Dougados merges many fields, such as Rheumatology and Rheumatoid arthritis, in his writings. He conducts interdisciplinary study in the fields of Osteoarthritis and Arthroplasty through his works. Maxime Dougados performs integrative Arthroplasty and Osteoarthritis research in his work.
His Surgery study in the realm of Radiography connects with subjects such as Nuclear medicine. Maxime Dougados undertakes interdisciplinary study in the fields of Surgery and Pathology through his research. His research on Pathology often connects related areas such as Osteoarthritis. In his articles, Maxime Dougados combines various disciplines, including Nuclear medicine and Radiography. Maxime Dougados is researching Alternative medicine as part of the investigation of Osteoarthritis and Placebo. In his works, Maxime Dougados conducts interdisciplinary research on Placebo and Alternative medicine. Maxime Dougados connects Internal medicine with Gastroenterology in his research. Maxime Dougados performs integrative Gastroenterology and Internal medicine research in his work. Maxime Dougados incorporates Rheumatoid arthritis and Rheumatology in his research.
Combining a variety of fields, including Odds ratio, Confidence interval and Logistic regression, are what the author presents in his essays. Maxime Dougados performs multidisciplinary studies into Confidence interval and Odds ratio in his work. Maxime Dougados merges many fields, such as Internal medicine and Family medicine, in his writings. He merges Family medicine with Internal medicine in his research. His research ties Fibromyalgia and Physical therapy together. He regularly links together related areas like Physical therapy in his Fibromyalgia studies. He performs multidisciplinary study in Rheumatoid arthritis and Rheumatism in his work. Maxime Dougados integrates several fields in his works, including Rheumatism and Rheumatoid arthritis. Disease connects with themes related to Antirheumatic Agents in his study.
Maxime Dougados undertakes interdisciplinary study in the fields of Internal medicine and Family medicine through his research. In his research, he undertakes multidisciplinary study on Family medicine and Internal medicine. Maxime Dougados performs integrative Rheumatoid arthritis and Rheumatism research in his work. In his articles, Maxime Dougados combines various disciplines, including Rheumatism and Rheumatoid arthritis. Maxime Dougados frequently studies issues relating to Expert opinion and Intensive care medicine. His Intensive care medicine research extends to Expert opinion, which is thematically connected. His work in Disease is not limited to one particular discipline; it also encompasses Antirheumatic Agents. His research on Antirheumatic Agents often connects related areas such as Disease. He integrates many fields in his works, including Psoriatic arthritis and Ankylosing spondylitis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection
M Rudwaleit;D van der Heijde;R Landewé;J Listing.
Annals of the Rheumatic Diseases (2009)
The European spondylarthropathy study group preliminary criteria for the classification of spondylarthropathy
Dougados M;van der Linden S;Juhlin R;Huitfeldt B.
Arthritis & Rheumatism (1991)
Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy : Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks
Stanley B Cohen;Paul Emery;Maria W Greenwald;Maxime Dougados.
Arthritis & Rheumatism (2006)
2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
Jasvinder A. Singh;Daniel E. Furst;Aseem Bharat;Jeffrey R. Curtis.
Arthritis Care and Research (2012)
Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition.
Mark C Genovese;Jean-Claude Becker;Michael Schiff;Michael Luggen.
The New England Journal of Medicine (2005)
The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis
J. Sieper;M. Rudwaleit;X. Baraliakos;J. Brandt.
Annals of the Rheumatic Diseases (2009)
The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general
M. Rudwaleit;D.M.F.M. van der Heijde;R.B.M. Landewé;N. Akkoc.
Annals of the Rheumatic Diseases (2011)
Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig.
Joel M Kremer;Rene Westhovens;Marc Leon;Eduardo Di Giorgio.
The New England Journal of Medicine (2003)
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force
Josef S Smolen;Ferdinand C Breedveld;Gerd R Burmester;Vivian Bykerk.
Annals of the Rheumatic Diseases (2016)
EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
Bernard Combe;Robert Landewé;Cedric Lukas;Horatio D Bolosiu.
Annals of the Rheumatic Diseases (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: